Correction: Significance of changes in cavity after treatment in Mycobacterium avium complex pulmonary disease. [PDF]
Kim JY +10 more
europepmc +1 more source
Radiologic phenotype-specific transcriptomic signatures in lung tissues from patients with Mycobacterium avium complex pulmonary disease. [PDF]
Lee JM +4 more
europepmc +1 more source
Association of lung field area with mortality in Mycobacterium avium complex lung disease: a longitudinal cohort study. [PDF]
Ogata H +9 more
europepmc +1 more source
Challenges and Efficacy of Amikacin Liposome Inhalation in Real-World Refractory Mycobacterium avium Complex Pulmonary Disease. [PDF]
Yanagihara T +8 more
europepmc +1 more source
Serum cytokine analysis in cavitary and non-cavitary pulmonary Mycobacterium avium complex disease: a cross-sectional study. [PDF]
Takeda K +15 more
europepmc +1 more source
Association between immunity and antimicrobial treatment resistance in patients with Mycobacterium avium complex pulmonary disease: a multicenter observational study. [PDF]
Matsuura A +10 more
europepmc +1 more source
Lipid accumulation and interstitial lung disease associated with amikacin liposomal inhalation suspension in patients with Mycobacterium avium complex lung disease: a single-center retrospective cohort study. [PDF]
Wakabayashi H +5 more
europepmc +1 more source
Mycobacterium avium Complex-Related Pulmonary Parenchyma Destruction: A Case Report. [PDF]
Viswanath A +3 more
europepmc +1 more source
Nutritional Status as a Risk Factor for the Early Discontinuation of Inhaled Liposomal Amikacin in Mycobacterium avium Complex Pulmonary Disease. [PDF]
Yamakawa H +10 more
europepmc +1 more source
Susceptibility testing of Mycobacterium avium complex isolates [PDF]
openaire +2 more sources

